Assessment of Knowledge on Pneumococcal Vaccination Among Diabetologists in India

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 20, 2023

Primary Completion Date

March 22, 2024

Study Completion Date

March 22, 2024

Conditions
Pneumococcal Vaccine
Interventions
OTHER

Pre and Post Education on practice of pneumococcal vaccination

A cross-sectional study will be conducted among 25 diabetologists in each of the four zones in India representing all directions - North, East, West and South. Diabetologists will be selected through purposive sampling. A semi-structured questionnaire (study tool) is designed based on the existing literature that addresses our objectives. An education session on Pneumococcal vaccination will be conducted for the diabetologists through webinar after completing the survey. A post assessment will be done using the same questionnaire among the study participants after the education session in order to see an increase in the knowledge of pneumococcal vaccination.

Trial Locations (1)

600013

M V Hospital for Diabetes [P] Limited, Chennai

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

MSD Pharmaceuticals LLC

INDUSTRY

lead

M.V. Hospital for Diabetes

OTHER

NCT05721092 - Assessment of Knowledge on Pneumococcal Vaccination Among Diabetologists in India | Biotech Hunter | Biotech Hunter